Search Results - robert+siliciano

3 Results

Sort By:

Novel HIV Antiviral Proteins and Their Uses in Therapeutic Methods

Unmet Need: HIV infection remains a significant global health burden despite availability of current antiviral treatments. With increasing drug resistance against available therapeutics, there is an urgent need for additional strategies to treat HIV. Technical Details: Researchers at Johns Hopkins University have identified novel candidates for HIV...

Published: 5/9/2024 | Inventor(s): David Thomas, Ashwin Balagopal, Ramy El-Diwany, Robert Siliciano, Joel Blankson, Stuart Ray, Michael Chattergoon, Justin Bailey

Keywords(s): Biomarker, Disease Indication, HIV, HIV/AIDS, Infectious Diseases, Mechanism-of-action Biomarker, Therapeutic Matter, Therapeutics, Viral Infections

Category(s): Clinical and Disease Specializations, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Infectious Diseases > HIV/AIDS, Clinical and Disease Specializations > Infectious Diseases > Viral Infections

HIV-1 Latency Cell Line Construction

Unmet NeedApproximately 38 million people are currently living with human immunodeficiency virus (HIV) globally. HIV is a serious health issue, and around 1 million people die from HIV/AIDS related illnesses each year. Currently, there is no cure for HIV, only prevention and treatment techniques exist. Current methods of treatment use antiretroviral...

Published: 5/10/2024 | Inventor(s): Robert Siliciano, Weiwei Dai

Keywords(s):

Category(s): Clinical and Disease Specializations > Infectious Diseases > Covid-19, Technology Classifications > Research Tools > Cell Lines

MH-Gag plasmid (Chimeric MLV/HIV-Gag) aka pSR389

TITLE: MH-Gag plasmid (Chimeric MLV/HIV-Gag) aka pSR389CASE NUMBER: C13554ABSTRACTJHU researchers made use of a chimeric Moloney murine leukemia virus (MMLV)-HIV-1 Gag in which the p17 matrix domain of HIV-1 was replaced with the p15 matrix and p12 domains from MMLV. Murine cells expressing this construct released significant amounts of VLPs. The construct...

Published: 5/9/2024 | Inventor(s): Robert Siliciano, Soon Boon Wong

Keywords(s): Cloning Reagents, Discovery/Research Tools, Disease Indication, HIV, HIV/AIDS, Infectious Diseases, Peptides, Plasmid, Recombinant Proteins, Research Reagent, Viral Infections

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Infectious Diseases > HIV/AIDS, Clinical and Disease Specializations > Infectious Diseases > Viral Infections, Technology Classifications > Research Tools > Proteins, Ligands & Receptors, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Research Tools